INS and Other metabolic disease: Due to the complexity of the pathway, the crosstalk with other ligands such as insulin-like growth factor (IGF1 and 2) with many downstream elements, and the specificity in different tissues, the mechanisms of regulation and inhibition of the insulin signaling pathway must be extremely controlled to avoid metabolic diseases.